BLAINJECTIONINJECTABLE5 Generics Approved
Approved
Oct 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
6
Data completeness
5/8 — Partial
HUMULIN R (insulin human) by Eli Lilly and Company. Approved for insulin [epc]. First approved in 1982.
Drug data last refreshed 22m ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HUMULIN R (insulin human) is a rapid-acting insulin approved in 1982 for the treatment of diabetes mellitus. It replaces or supplements endogenous insulin production to regulate blood glucose levels in patients requiring insulin therapy.
$0.052BPart D
LOE ApproachingProduct is approaching loss of exclusivity with moderate Part D spending; brand teams face consolidation and cost-management focus.
Mechanism of Action
Pharmacologic Class:
Insulin
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (6)
Comparative Study of Rinsulin R (GEROPHARM) and Humulin Regular (Eli Lilly) Euglycemic Hyperinsulinemic Clamp Method
Started Feb 2018
20 enrolled
BioequivalenceTherapeutic Equivalency
Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes
Started Jan 2011
13 enrolled
DiabetesDiabetes Mellitus, Type 1
Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20
Started Nov 2008
42 enrolled
Healthy Volunteers
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics
Started Aug 2008
28 enrolled
Diabetes
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.
Started Jul 2008
42 enrolled
Diabetes
Worked on HUMULIN R at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.